You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Xerophthalmia

Showing 1 - 25 of 110
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Dry Eye Syndrome, Sjogren's Syndrome, Xerophthalmia Trial in Taipei (Chinese herbal tea VGH-DESJS-1)

Not yet recruiting
  • Dry Eye Syndrome
  • +2 more
  • Chinese herbal tea VGH-DESJS-1
  • Taipei, Taiwan
    Ching-Mao Chang
Dec 19, 2022

Dry Eye Syndrome, Xerophthalmia Trial (Acupuncture, Oral microbiota, Schirmer's test)

Recruiting
  • Dry Eye Syndrome
  • Xerophthalmia
  • Acupuncture
  • +14 more
  • Taipei, Taiwan
    Ching-Mao Chang
Dec 11, 2022

Upper Blepharoplasty on Vision Quality in Early Postoperative

Recruiting
  • Excess Skin of Both Eyelids
  • +3 more
  • Upper blepharoplasty
  • Osijek, Croatia
    Osijek University Hospital
Sep 21, 2022

Xerophthalmia Trial (Intense pulsed light therapy, Hot compress massage)

Withdrawn
  • Xerophthalmia
  • Intense pulsed light therapy
  • Hot compress massage
  • (no location specified)
Nov 12, 2020

Sjogren's Syndrome Trial in Ribeirão Preto (Acupuncture, Sham acupuncture)

Unknown status
  • Sjogren's Syndrome
  • Acupuncture
  • Sham acupuncture
  • Ribeirão Preto, São Paulo, Brazil
    School of Dentistry of Ribeirão Preto, University of São Paulo
Mar 25, 2020

HRR as a Novel Biomarker in Sjögren's Syndrome

Completed
  • Sjögren's Syndrome
  • blood sample analysis
  • Tianjin, Tianjin, China
    Tianjin Eye Hospital
Nov 30, 2022

Sleep Initiation and Maintenance Disorders Trial (QUALI)

No longer available
  • Sleep Initiation and Maintenance Disorders
  • (no location specified)
Feb 23, 2023

Thyroid Trial in Philadelphia (Metformin Hydrochloride, Radioactive Iodine, Placebo)

Active, not recruiting
  • Thyroid
  • Metformin Hydrochloride
  • +2 more
  • Philadelphia, Pennsylvania
    Sidney Kimmel Cancer Center at Thomas Jefferson University
Aug 31, 2021

Primary Sjögren's Syndrome Trial in Worldwide (S95011 concentrate for solution for infusion, Placebo concentrate for solution

Active, not recruiting
  • Primary Sjögren's Syndrome
  • S95011 concentrate for solution for infusion
  • Placebo concentrate for solution for infusion
  • Beverly Hills, California
  • +27 more
Jan 13, 2023

Tear Film Insufficiency, Dry Eye Trial in Guangzhou (0.1% sodium hyaluronate)

Unknown status
  • Tear Film Insufficiency
  • Dry Eye
  • 0.1% sodium hyaluronate
  • Guangzhou, Guangdong, China
    Zhongshan Ophthalmic Center, Sun Yat-Sen University
Jan 23, 2019

Nocturia, Sleep Disorder Trial in Zurich (Bryophyllum pinnatum 50 %, tablets into capsules (verum: 2x2capsules/day))

Completed
  • Nocturia
  • Sleep Disorder
  • Bryophyllum pinnatum 50 %, tablets into capsules (verum: 2x2capsules/day)
  • Zurich, Switzerland
    University of Hospital, Clinic for Gynecology
Jan 16, 2022

Sjogren's Syndrome Trial in Reims (Evaluation of olfactory function, Evaluation of taste function, Evaluation of (intra-nasal

Not yet recruiting
  • Sjogren's Syndrome
  • Evaluation of olfactory function
  • +2 more
  • Reims, France
    Université de Reims Champagne-Ardenne
May 24, 2022

Dry Eye Syndrome, Healthy Control, Sjögren's Syndrome and Other

Not yet recruiting
  • Dry Eye Syndrome
  • +3 more
  • Whole-genome genotyping
  • +11 more
  • Taipei, Taiwan (r.o.c.), Taiwan
    Ching-Mao Chang
Aug 9, 2022

Dry Eye Syndrome, Tear Film Insufficiency Trial in Catania, Messina (Lubricin, Sodium Hyaluronate)

Completed
  • Dry Eye Syndrome
  • Tear Film Insufficiency
  • Lubricin
  • Sodium Hyaluronate
  • Catania, Italy
  • +1 more
Jan 28, 2019

Systemic Sclerosis Trial in Brest, Rennes, Tours (Minor Salivary gland Biopsy, ARFI, MSG US)

Completed
  • Systemic Sclerosis
  • Minor Salivary gland Biopsy
  • +2 more
  • Brest, France
  • +2 more
Apr 4, 2022

Helminthiasis Trial (albendazole BENDEX, albendazole OVIS)

Completed
  • Helminthiasis
  • albendazole BENDEX
  • albendazole OVIS
  • (no location specified)
Dec 22, 2021

Metastatic Castration-resistant Prostate Cancer Trial ([177Lu]Ludotadipep 3.7 GBq)

Not yet recruiting
  • Metastatic Castration-resistant Prostate Cancer
  • [177Lu]Ludotadipep 3.7 GBq
  • (no location specified)
Jul 12, 2022

Dry Eye, Dry Eye Syndrome, Blepharitis Trial in London (Artificial tears (classified by MHRA as a medical device))

Unknown status
  • Dry Eye
  • +9 more
  • Artificial tears (classified by MHRA as a medical device)
  • London, United Kingdom
  • +1 more
Aug 29, 2018

Breast Cancer Trial in Japan (Paclitaxel)

Completed
Has Results
  • Breast Cancer
  • Nagoya, Aichi, Japan
  • +3 more
May 3, 2021

Primary Sjögren Syndrome Patients

Active, not recruiting
  • Sjogren's Syndrome
  • Parallel Assignment
  • São Paulo, Sao Paulo, Brazil
  • +1 more
Nov 7, 2022

Hypermetabolic Lymphadenopathy Mediastinum Lower, Posterior and Middle, Detected by PET-CT With 18F-FDG (PET) Trial in Bordeaux

Completed
Has Results
  • Hypermetabolic Lymphadenopathy Mediastinum Lower, Posterior and Middle, Detected by PET-CT With 18F-FDG (PET)
  • Guided punction of mediastinal lymphadenopathy by echoendoscopy
  • PET scan
  • Bordeaux, Grionde, France
    Insitut Bergonie
Apr 26, 2021

Dry Eye Syndrome, Tear Film Insufficiency Trial (Tear Film Imager, Restasis)

Unknown status
  • Dry Eye Syndrome
  • Tear Film Insufficiency
  • (no location specified)
Jan 11, 2018

Triple Negative Breast Cancer Trial in Worldwide (SAR566658 (ACT14884))

Terminated
Has Results
  • Triple Negative Breast Cancer
  • SAR566658 (ACT14884)
  • Leuven, Belgium
  • +12 more
Aug 11, 2021

Sjogren's Syndrome Trial in São Paulo (Periodontal scaling)

Active, not recruiting
  • Sjogren's Syndrome
  • Periodontal scaling
  • São Paulo, Sao Paulo, Brazil
  • +2 more
Oct 14, 2021

Breast Cancer Trial in United States (pertuzumab in combination with trastuzumab and paclitaxel)

Completed
Has Results
  • Breast Cancer
  • pertuzumab in combination with trastuzumab and paclitaxel
  • Basking Ridge, New Jersey
  • +5 more
Jul 17, 2020